Duman, Mert http://orcid.org/0000-0003-4277-6272
Vaquié, Adrien http://orcid.org/0000-0003-1463-0153
Nocera, Gianluigi
Heller, Manfred
Stumpe, Michael
Siva Sankar, Devanarayanan
Dengjel, Jörn http://orcid.org/0000-0002-9453-4614
Meijer, Dies http://orcid.org/0000-0002-8461-6341
Yamaguchi, Teppei http://orcid.org/0000-0002-5043-5315
Matthias, Patrick http://orcid.org/0000-0002-3927-1452
Zeis, Thomas
Schaeren-Wiemers, Nicole http://orcid.org/0000-0002-6554-4725
Hayoz, Antoinette
Ruff, Sophie
Jacob, Claire http://orcid.org/0000-0001-9567-3950
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00P3_1139163, PP00P3_163759 and 31003A _173072)
International Foundation for Research in Paraplegia (P 174)
Schweizerische Multiple Sklerose Gesellschaft
Olga Mayenfisch Stiftung Forschungspool of the University of Fribourg
Article History
Received: 6 September 2019
Accepted: 19 June 2020
First Online: 9 July 2020
Competing interests
: Patent application # EP17174916.1 filed in Europe on 8 June 2017 and internationally on 8 June 2018 (application # PCT/EP2018/065168), applicant = University of Fribourg, Switzerland, inventor: Claire Jacob, under evaluation, title: HDAC1/2 activator for promoting and/or accelerating myelination and/or remyelination. The authors declare no other competing interest.